Epidermal growth factor receptor, C-kit, and Her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the 2004 World Health Organization in patients treated with octreotide and prednisone: an Eastern Cooperati
about
KRAS, EGFR, PDGFR-α, KIT and COX-2 status in carcinoma showing thymus-like elements (CASTLE)Emerging treatment options for patients with recurrent advanced thymic epithelial tumorsMolecular genetic alterations in egfr CA-SSR-1 microsatellite and egfr copy number changes are associated with aggressiveness in thymoma.c-kit mutation-positive advanced thymic carcinoma successfully treated as a mediastinal gastrointestinal stromal tumor: A case report.Thymic malignancies: from clinical management to targeted therapies.Chemotherapy and targeted agents for thymic malignancies.Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors.Capecitabine plus gemcitabine in thymic epithelial tumors: final analysis of a Phase II trial.Patterns of metastasis and recurrence in thymic epithelial tumours: longitudinal imaging review in correlation with histological subtypes.Protein expression status of p53 and epidermal growth factor receptor in thymoma.Immunohistochemical analysis of thymic carcinoma focusing on the possibility of molecular targeted and hormonal therapies.Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas.
P2860
Q33835833-E9B4CA53-659E-4BA4-A686-E53EF15AA0B9Q36228352-29AD50FF-F268-42EA-B885-9EBE41FA7E08Q36724092-38CAEF9C-1332-4B81-A2CC-52F968B5C827Q36741396-0CF67339-987B-4380-B602-A2184A6A3731Q36910414-02314DD9-89BA-4409-980A-43994E2E547FQ38010806-8739CA29-7F6A-45B4-8E26-801751B29C8CQ38269843-6A83A324-9DE7-4B89-A44A-6A4ED02136A4Q38282448-B456B2C8-9663-47DF-9064-B55B4889293AQ38856818-701F9B4E-521E-43C0-B935-FB67C5EAB694Q42259267-7DE47DA5-C5E0-4869-8774-5C82CAAE4692Q50905277-7FCEDDD4-FD1E-4E3B-8FB4-C2EA05B7D86DQ54504171-B195B412-0D81-456C-93BC-0E046257C04B
P2860
Epidermal growth factor receptor, C-kit, and Her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the 2004 World Health Organization in patients treated with octreotide and prednisone: an Eastern Cooperati
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Epidermal growth factor recept ...... ednisone: an Eastern Cooperati
@ast
Epidermal growth factor recept ...... ednisone: an Eastern Cooperati
@en
Epidermal growth factor recept ...... ednisone: an Eastern Cooperati
@nl
type
label
Epidermal growth factor recept ...... ednisone: an Eastern Cooperati
@ast
Epidermal growth factor recept ...... ednisone: an Eastern Cooperati
@en
Epidermal growth factor recept ...... ednisone: an Eastern Cooperati
@nl
prefLabel
Epidermal growth factor recept ...... ednisone: an Eastern Cooperati
@ast
Epidermal growth factor recept ...... ednisone: an Eastern Cooperati
@en
Epidermal growth factor recept ...... ednisone: an Eastern Cooperati
@nl
P2093
P2860
P1476
Epidermal growth factor recept ...... operative Oncology Group study
@en
P2093
David H Johnson
David S Ettinger
Joan H Schiller
Joseph Aisner
Meera R Hameed
Patrick J Loehrer
Seena C Aisner
P2860
P304
P356
10.1097/JTO.0B013E3181D86A30
P577
2010-06-01T00:00:00Z